Related Experiment Video
Updated: Aug 26, 2025
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
Growth Differentiation Factor-15 as a Candidate Biomarker in Gynecologic Malignancies: A Meta-analysis
Dipayan Roy1, Anupama Modi1, Purvi Purohit1
1Department of Biochemistry, AIIMS, Jodhpur, India.
Cancer Investigation
|October 6, 2022
Summary
Growth differentiation factor-15 (GDF-15) shows potential as a diagnostic marker for gynecological cancers. This meta-analysis indicates GDF-15 can help differentiate malignant from non-malignant gynecological tumors.
Area of Science:
- Oncology
- Biomarker Discovery
- Gynecologic Oncology
Background:
- Growth differentiation factor-15 (GDF-15) is a novel protein with emerging roles in various cancers.
- Its diagnostic utility in gynecological cancers requires further clinical validation.
- Current diagnostic methods may benefit from supplementary markers for improved accuracy.
Approach:
- A comprehensive meta-analysis was conducted using data from six eligible studies.
- Studies included histopathologically confirmed cases of gynecological cancers without prior treatment.
- Diagnostic accuracy data for GDF-15 was systematically extracted and analyzed.
Key Points:
- The meta-analysis revealed a pooled diagnostic odds ratio of 12.74 for GDF-15.
- GDF-15 demonstrated a sensitivity of 80.5% and a specificity of 74.1%.
- The area under the curve (AUC) was calculated to be 0.84, indicating good diagnostic performance.
Conclusions:
- GDF-15 exhibits significant potential as a biomarker for differentiating gynecological malignancies.
- The findings support the consideration of GDF-15 in the clinical diagnostic workup of gynecological tumors.
- Further research may refine the role of GDF-15 in gynecological cancer diagnostics.
